innerbanner mobile

About Resmed

Resmed ensures rest feels right by quality sleep and respiratory care—combining innovation with sleep therapy to support an easy life. Our mission is to make advanced, non-invasive technology accessible to more people, helping them understand, manage and overcome sleep-related breathing issues with confidence. Because when you breathe easier at night, you live finer every day.

We pioneer cloud-connected medical devices and comprehensive software platforms designed to empower individuals with sleep apnea, COPD, and other chronic respiratory conditions. By enabling personalized, effective care in home and clinical settings, we help people live healthier, higher-quality lives while reducing healthcare costs. Operating in over 140 countries, Resmed is committed to bridging the gap between advanced healthcare technology and everyday life. Our vision is to transform healthcare by enabling easier breathing and healthier living, one breath at a time.

156 M+

lives changed in the last 12 months

20.5M+

100% cloud-connectable devices on the market

7.5M+

CPAP users have signed up for myAir

9500+

Patents and designs

14.5B+

Nights of medical sleep and respiratory care data

7-8 %

of annual revenue invested back into R&D

Our Story
1981
1981

In 1981 Professor Colin Sullivan and colleagues at the University of Sydney developed the first continuous positive airway pressure (CPAP) device, the first successful, non-invasive treatment for obstructive sleep apnea (OSA). After publishing the successful results in Lancet, Sullivan, who had patented the technology, sought a compatible partner to help commercialise this life-changing technology.

1986
1986

In 1986 he approached Chris Lynch, Managing Director of the Baxter Centre for Medical Research and Vice President of R&D for Baxter Healthcare, who in turn reached out to his Baxter co-worker Dr. Peter Farrell.

1987
1987

In 1987 Farrell, on behalf of Baxter, invested in Sullivan’s technology to further evolve the CPAP prototype and undertake clinical trials on a group of patients with severe sleep apnea.

1989
1989

In 1989, after Baxter decided not to enter the sleep apnea market for a variety of reasons, Farrell founded Resmed (short for “Respiratory Medicine”) to buy Sullivan’s sleep technology from Baxter and to commercialise his prototype CPAP device to allow scalable device production – in other words, to bring CPAP to the world at large.

2014
2014

Since then, Resmed has delivered on Farrell’s promise: making CPAP masks, CPAP machines and in-home life support ventilators more comfortable, quieter and easier to use.

2025
2025

Today, we help people with sleep apnea, COPD and other chronic respiratory diseases breathe and live easier.

1981
1986
1987
1989
2014
2025

Our Drive to Innovate

We’re leading the way in cloud-connected medical devices that transform care for people with sleep apnea, COPD and other chronic disease.

Our Mission

Our mission is to change 250 million lives in 2025. We're proud to make equipment and connected health solutions that give those with sleep apnoea, COPD and other respiratory diseases the gift of breath.

Our Vision

At Resmed, we believe that every breath is a gift. And from the day we began pioneering sleep apnoea treatment options in 1989, our aim has been to deliver life-changing products and solutions to patients with sleep apnoea and other respiratory conditions worldwide, and to spread awareness about these conditions and treatments.

Environmental Policy

  • Resmed’s mission statement
  • Responsibility
  • Environmental policy statement
Resmed’s mission statement

Resmed changes lives by developing, manufacturing and distributing innovative medical devices and cloud-based software solutions to better diagnose, treat, and manage sleep-disordered breathing, COPD, and other key chronic diseases.

Responsibility

Resmed changes lives by developing, manufacturing and distributing innovative medical devices and cloud-based software solutions to better diagnose, treat, and manage sleep-disordered breathing, COPD, and other key chronic diseases.

Environmental policy statement

Resmed changes lives by developing, manufacturing and distributing innovative medical devices and cloud-based software solutions to better diagnose, treat, and manage sleep-disordered breathing, COPD, and other key chronic diseases.

Our Culture

We value fostering a positive culture of belonging, inclusion, and diversity so that everyone can be their best self at Resmed. We work hard to make sure everyone is seen, valued, and engaged.